Clinical trial
Evaluation of the TriActiv ProGuard System During Carotid Artery Stenting
NCT00395785 · Kensey Nash Corporation, Industry · Terminated
Key facts
| NCT number | NCT00395785 |
|---|---|
| Title | Evaluation of the TriActiv ProGuard System During Carotid Artery Stenting |
| Official title | Protection During Carotid Stenting in High Risk Patients With the TriActiv ProGuard System |
| Lead sponsor | Kensey Nash Corporation, Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Carotid Stenosis |
| Intervention type | Device |
| Interventions | Carotid Stent Implantation, Embolic Protection |
| Enrollment | 400 |
| Start date | Nov 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Nov 3, 2006 |
| Last update posted | Jul 25, 2007 |
| Countries | Germany, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: